Create accountLogin

Recent searches

No recent searches

Search options

Only available when logged in.
en.osm.town is one of the many independent Mastodon servers you can use to participate in the fediverse.
An independent, community of OpenStreetMap people on the Fediverse/Mastodon. Funding graciously provided by the OpenStreetMap Foundation.

Administered by:

Server stats:

265
active users

en.osm.town: AboutProfiles directoryPrivacy policy

Mastodon: AboutGet the appKeyboard shortcutsView source codev4.3.7

#pharma

1 post1 participant0 posts today
Public
The Times Of India

Amidst the ongoing conflict, a Russian missile struck the warehouse of Indian pharmaceutical company Kusum in Ukraine, according to the Ukrainian embassy in India. The embassy criticized Russia's actions as a deliberate attack on Indian businesses, destroying medicines intended for children and the elderly, despite claiming a special friendship with India.
#pharma #Ukraine #MastIndia #MastodonIndians #India @mastodonindians
timesofindia.indiatimes.com/in

The Times of India'Special friendship?': Russian missile hit warehouse of Indian firm, claims Ukraine | India News - The Times of IndiaIndia News: Amidst the ongoing conflict, a Russian missile struck the warehouse of Indian pharmaceutical company Kusum in Ukraine, according to the Ukrainian emba
Continued thread
Public *
petersuber

Update. New study: "#NIH investment in drugs approved from 2010 to 2019 was not less than investment by the #pharmaceutical industry, with comparable accounting for basic and applied research, failed clinical trials, and cost of capital or discount rates."
jamanetwork.com/journals/jama-

PS: Relevant to (1) #Trump admin cutbacks to NIH #funding and (2) industry #patents and licensing terms on approved drugs.

#Medicine#Pharma
Public *
Skeptix

📰 | Librela im Faktencheck: Schmerztherapie für Hunde mit Arthrose

Der #Südkurier hat Hundebesitzer:innen in Angst versetzt, als er das Schmerzmedikament #Librela als „tödliches Wundermittel“ bezeichnete und recht drastisch bebilderte.

@karopa, selbst praktizierende Tierärztin, klärt im #SkeptixBlog nüchtern über die Wirkweise des Medikamentes und über die Sicherheit von Arzneimittel in Veterinär- und Humanmedizin auf.

skeptix.org/2025/03/16/librela

Skeptix · Librela im Faktencheck: Schmerztherapie für Hunde mit Arthrose - SkeptixAktuell wird behauptet, das Schmerzmittel für Hunde Librela sei gefährlich und habe für tausende Hunde den Tod bedeutet. Ein Faktencheck.
#hund#medizin#pharma
Public *
-karlos-

Die 100.000 €-Verschwörung

Was, wenn deine Lieblingshomöopathin selbst gar keine Globuli nimmt, sondern nur so tut? Was, wenn dein Heilpraktiker, der vor "Schulmedizin" warnt, sich heimlich regelmäßig Ibu800 reinpfeift? Was, wenn der Guru, der seinen Krebs angeblich durch "Quantenenergie" geheilt hat, in Wirklichkeit bei ner Chemo war?

youtu.be/p_gbuXacPq8
#Verschwörung #Pharma #Pharmaindustrie

YouTubeDie 100.000€-VerschwörungBy MAITHINK X
Public
MEZIS e.V.

Veranstaltungshinweis: Influencer - wie sie ticken und tocken
Gute Arzneimittelinfo - oder einfach nur Reklame?

Donnerstag, 27. Februar 2025, 20-21:30 Uhr, online:
vdpp.de/termine/fr%C3%BChlings
vom Verein demokratischer Pharmazeutinnen und Pharmazeuten (VdPP):

- Wer inszeniert was in den sozialen Medien?
- Wird den Bedürfnissen der Patient:innen überhaupt Rechnung getragen?
- Wie ist das arzneimittelrechtlich einzuordnen?
- Gibt es politischen Handlungsbedarf?

Eines dieser krassen Beispiele von #NovoNordisk hatten wir zuletzt auch beleuchtet:
mezis.de/laienwerbung-von-novo

#mezis#pharma
Public
Miguel Afonso Caetano

"China’s biotech boom mirrors its rise in tech. In both cases, China has moved up the value chain, from manufacturing goods to becoming a more sophisticated hub for innovation, competing in industries once dominated by the U.S. There are several reasons for the industry’s growth. For one, many top scientists trained in the U.S. have returned to China over the past decade, fueling the emergence of biotech hubs around Shanghai. And just as DeepSeek built a formidable chatbot—allegedly on a lean budget with limited access to semiconductors—Chinese biotech companies are also scrappier, capitalizing on a highly skilled, lower-cost workforce that can move faster.

Additionally, companies can conduct clinical trials at a fraction of what they would cost in the U.S., while recent changes in the Chinese regulatory system have streamlined and accelerated the approval process to get a study started.

For now, much of China’s biotech innovation is incremental rather than groundbreaking. Many companies focus on improving existing drugs—tweaking the chemistry, enhancing efficacy or differentiating them in key ways.

But Chinese innovation is steadily improving and is already starting to disrupt the U.S. drug-development ecosystem. For decades, the U.S. biotech industry has thrived in hubs such as Boston-Cambridge and the San Francisco Bay Area, fueled by talent streaming from top academic centers like Massachusetts Institute of Technology and Stanford University. Those biotech companies have an insatiable client in Big Pharma, which is willing to pay top dollar for new drugs to replace those going off-patent."

wsj.com/health/pharma/the-drug

#China#BioTech#DrugIndustry
Public *
Salty Daddy 🏳️‍🌈 🇺🇦 ✡️

My latest refill of PreP (anti-HIV Rx) perfectly demonstrates why medications are so grossly overpriced in the US.

The plain white bottle was an earlier refill and the fancy card fold-out with individual blister packed pills (I hate those) is the latest. The cost of this uselessly-expensive and unnecessarily-complex packaging is about 10x that of the simple plastic bottle. It adds nothing except a barrier to use for anyone with manual dexterity issues, missing digits, amputees, etc. It also cannot be recycled, not with all that plastic and foil mixed in with the heavily-coated paperboard.

Fuck you, Gilead Sciences, Inc. 🖕🏻🖕🏻🖕🏻🖕🏻 #Pharma

Photo of two 30-day doses of Descovy. One is a plain white plastic bottle. The other is a complicated mess of card stock and individual pill packs.
Replied in thread
Public *
Strypey

Here are 2 fundamental problems with the existing medical system;

1) the public directly fund the majority of medical research but outsource control of the studies, and ownership of the outputs;

tni.org/en/podcast/why-we-need

2) companies selling medical products are allowed to conduct their own studies on safety and efficacy in private. So they can cherry-pick which ones to publish, based on what makes their products look good, and bury the rest.

(1/?)

#pharma

@sullybiker

Transnational InstituteWhy we need to break Big Pharma's Power before the next Pandemic hits | Transnational InstituteHow is it that drug companies can make huge profits from vaccines while people in the global South die from lack of access to medical care? How does the global regime of intellectual property rights enable this inequality? And what is the role of Bill Gates in defending this system? 
Continued thread
Public *
J. Steven York RESISTS

So why, you ask, was Levimir discontinued? Maker Novo Nordisk got upset about insulin price laws and decided they could make more money making Ozempic (which ironically I ALSO take, for diabetes, not for weight loss). Why is access to insulin seemingly controlled as much (or more) than opioids? I suspect it's because of rules and state laws that were likely written by big-pharma lobbyists to control the trade.
#usHealthCare #pharma #novoNordisk #insulin #diabetes #ozempic #levimir

Public
Brittany Trang

Today is the LAST day to get 3 mo of STAT+ for $10, so I'm highlighting some of my favorite 2024 stories.

Your subscription makes it possible to hold the healthcare system to account through Pulitzer-recognized investigations, deeply personal stories, & incisive reporting on tomorrow's problems. 🧵

marketing.statnews.com/stat-pl

marketing.statnews.comHappy holidays! Get your first 3 months of STAT+ for $10.For a limited time only, get three months of STAT+ for just $10.
#health#healthcare#medicine
ExploreLive feeds
About